(Q39086982)

9 September 2017

title

Recombinant lipoproteins reinforce cytotoxicity of doxorubicin to hepatocellular carcinoma (English)

1 reference

9 September 2017

0 references

1 reference

Baolong Wang

1

1 reference

9 September 2017

Yuan Yuan

2

1 reference

9 September 2017

Lei Han

3

1 reference

9 September 2017

Li Ye

4

1 reference

9 September 2017

Xunlong Shi

5

1 reference

9 September 2017

Meiqing Feng

6

1 reference

9 September 2017

publication date

4 October 2013

1 reference

Journal of Drug Targeting

9 September 2017

published in

1 reference

9 September 2017

volume

22

1 reference

9 September 2017

issue

1

1 reference

9 September 2017

page(s)

76-85

1 reference

Pathobiology of chemotherapy-induced hair loss

9 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.839687

Effects of high-dose chemotherapy on bone marrow multipotent mesenchymal stromal cells isolated from lymphoma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.839687

Therapeutic nanoparticles for drug delivery in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.839687

Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.839687

Impact of nanotechnology on drug delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.839687

Targeting of nanoparticles in cancer: drug delivery and diagnostics

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.839687

Resistance mechanisms associated with altered intracellular distribution of anticancer agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.839687

Biodistribution and toxicity of engineered gold nanoparticles: a review of in vitro and in vivo studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.839687

A review of nanoparticle functionality and toxicity on the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.839687

Hemocompatibility of liposomes loaded with lipophilic prodrugs of methotrexate and melphalan in the lipid bilayer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.839687

A biomimetic nanovector-mediated targeted cholesterol-conjugated siRNA delivery for tumor gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.839687

Targeted delivery of small interfering RNA using reconstituted high-density lipoprotein nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.839687

Recombinant lipoproteins: lipoprotein-like lipid particles for drug targeting.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.839687

Recombinant high density lipoprotein nanoparticles for target-specific delivery of siRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.839687

High-density lipoprotein heterogeneity and function in reverse cholesterol transport

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.839687

A mutant high-density lipoprotein receptor inhibits proliferation of human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.839687

Accelerated blood clearance (ABC) phenomenon upon repeated injection of PEGylated liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.839687

HDL as a contrast agent for medical imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.839687

Delivery of hydrophilic drug doxorubicin hydrochloride-targeted liver using apoAI as carrier

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.839687

High yield and secretion of recombinant human apolipoprotein AI in Pichia pastoris

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.839687

Doxorubicin and paclitaxel-loaded lipid-based nanoparticles overcome multidrug resistance by inhibiting P-glycoprotein and depleting ATP.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.839687

Cyclic RGD peptide-modified liposomal drug delivery system: enhanced cellular uptake in vitro and improved pharmacokinetics in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.839687

Targeted magnetic liposomes loaded with doxorubicin.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.839687

PEGylated PLGA nanoparticles for the improved delivery of doxorubicin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.839687

A LDL-masked liposomal-doxorubicin reverses drug resistance in human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.839687

High-density lipoprotein as a potential carrier for delivery of a lipophilic antitumoral drug into hepatoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.839687

Apolipoprotein A-I (apoA-I) and apoA-I mimetic peptides inhibit tumor development in a mouse model of ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.839687

L-5F, an apolipoprotein A-I mimetic, inhibits tumor angiogenesis by suppressing VEGF/basic FGF signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.839687

D-4F, an apoA-I mimetic peptide, inhibits proliferation and tumorigenicity of epithelial ovarian cancer cells by upregulating the antioxidant enzyme MnSOD.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.839687

Review of tests for monitoring doxorubicin-induced cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.839687

Cardiac toxicity in breast cancer survivors: review of potential cardiac problems.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.839687

Doxorubicin as a molecular nanotheranostic agent: effect of doxorubicin encapsulation in micelles or nanoemulsions on the ultrasound-mediated intracellular delivery and nuclear trafficking

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.839687

In vitro cytotoxicity assays: comparison of LDH, neutral red, MTT and protein assay in hepatoma cell lines following exposure to cadmium chloride

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.839687

Morphological features of cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.839687

Doxorubicin induces apoptosis in normal and tumor cells via distinctly different mechanisms. intermediacy of H(2)O(2)- and p53-dependent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.839687

HDL drug carriers for targeted therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.839687

Liver targeting and anti-HBV activity of reconstituted HDL-acyclovir palmitate complex

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.839687

10.3109/1061186X.2013.839687

21 January 2018

Identifiers

DOI

1 reference

9 September 2017

1 reference